Cargando…
Aplastic anemia secondary to dual cancer immunotherapies a physician nightmare: case report and literature review
BACKGROUND: Treatment with immune checkpoint inhibitors has revolutionized cancer treatment over the past several years. Despite their clinical benefits, a wide range of immune-mediated toxicities can be observed including hematological toxicities. Although, the majority can easily be managed, immun...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549247/ https://www.ncbi.nlm.nih.gov/pubmed/34702371 http://dx.doi.org/10.1186/s13223-021-00616-4 |